Seven consecutive months of record revenue ᅠ.
Since March, Sina Pharmaceuticals has recorded a higher income than the previous month. The monthly income increased from 79 billion tomans in March to about 1.2 hemet quickly. The income for seven months was about 5.4 MET, which is 120% more than the corresponding period and was 28% ahead of the total income last year. The average monthly income increased from about 500 billion tomans in the first season to 883 billion tomans in the second season. Mehr grew by 171% compared to the same month last year.
ᅠ value investment ᅠ.